Lyme België/ Belgique Protest

De huidige CBO-richtlijn voldoet niet en zou vervangen moeten worden door die van ILADS. Er is geen behandeling en vergoeding. Patiënten wijken uit naar artsen die niet door de zorgverzekeraar worden vergoed. Zelfs de NGC (voor evidence-based richtlijnen) heeft de ILADS richtlijn opgenomen.

I See You, #ChronicIllness Fighter #Lyme #LymeDisease #ISeeYou

I see you, pushing yourself, day after day, to get up and out of bed, fighting through the tears. I see you slowly crawling your way to the bathroom to get yourself to the next room. I see your smile, the one you muster up in front of family and friends, saying you’re fine, looking at the clock and just wanting to go home. I see you cancelling plans with friends, a night out with your significant other, again, while buckled over in pain on the floor. I see you, warrior.

https://themighty.com/2018/12/chronic-illness-warriors-i-see-you/?fbclid=IwAR3FW5e1i0Od-OxiVllkdquq5Fb4mi81eJUmuqS_3nC7fXj8x9nhjr6YYsk

Minister van Volksgezondheid Maggie De Block (Open VLD) vindt het geen goed idee om de ereloonsupplementen bij ziekenhuisopnames te verbieden, zoals CM voorstelt.

The Emerging Role of Microbial #Biofilm in #Lyme Neuroborreliosis #Neurology #Persistence #InfectiousDisease

Lyme neuroborreliosis (LNB) is the most dangerous manifestation of Lyme disease, occurring in 10–15% of infected individuals. During the course of the infection, bacteria migrate through the host tissues altering the coagulation and fibrinolysis pathways and the immune response, reaching the central nervous system (CNS) within 2 weeks after the bite of an infected tick. The early treatment with oral antimicrobials is effective in the majority of patients with LNB. Nevertheless, persistent forms of LNB are relatively common, despite targeted antibiotic therapy. It has been observed that the antibiotic resistance and the reoccurrence of Lyme disease are associated with biofilm-like aggregates in B. burgdorferi, B. afzelii, and B. garinii, both in vitro and in vivo, allowing Borrelia spp. to resist to adverse environmental conditions. Indeed, the increased tolerance to antibiotics described in the persisting forms of Borrelia spp., is strongly reminiscent of biofilm growing bacteria, suggesting a possible role of biofilm aggregates in the development of the different manifestations of Lyme disease including LNB.

B. burgdorferi infection of the CNS cause mainly encephalitis, segmental myelitis, cranial neuritis, radiculoneuritis, vasculitis, and intracranial hypertension (13, 15, 16). The clinical manifestation of the LNB may include ataxia, paraparesis, sphincter dysfunction, Parkinson-like symptoms, confusion and cognitive impairment (17, 18). Ischemic stroke is the most frequent cerebrovascular manifestation of LNB presenting in 76% of cases, followed by transient ischemic attack (11%) (19).

https://www.frontiersin.org/articles/10.3389/fneur.2018.01048/full